Japan Tissue Engineering Hits Day Low at JPY 654 Amid Price Pressure

Japan Tissue Engineering Co., Ltd. experienced significant volatility in its stock performance today, closing down by 7.97% on March 12, 2026. The stock reached an intraday low of JPY 654.00, reflecting a challenging trading environment. In terms of performance metrics, Japan Tissue Engineering has shown a decline of 9.99% over the past week, contrasting with a modest 1.49% drop in the Japan Nikkei 225 index. Over the last month, however, the company has managed a positive return of 11.53%, while the Nikkei 225 has decreased by 5.53%. Despite a year-to-date increase of 5.79%, the company's long-term growth appears limited, with net sales growing at an annual rate of just 1.23% over the past five years. The company reported a pre-tax profit of JPY -183.82 million, marking a significant decline of 85.11%. Additionally, the return on equity stands at a low 0.47%, indicating challenges in generating profitability from shareholders' funds. Overall, Japan Tissue Engineering Co., Ltd. continues to navigate a complex financial landscape within the pharmaceuticals and biotechnology sector.